The Skeptic

Open-weight vision model fine-tuned for radiology and clinical imaging

“Category is open-weight medical vision LLM; direct competitors are Google's Med-PaLM 2 and Microsoft's BiomedCLIP, both of which are closed or heavily gated — so Meta's move to open weights is genuinely differentiated, not just marketing. The scenario where this breaks is any real clinical deployment: the research license explicitly forbids diagnostic use, so the addressable user is a researcher with GPU access, not a radiologist. What kills this in 12 months is not a competitor but regulatory clarity — if the FDA signals that research-licensed models can't touch real patient workflows even in research contexts, the use case shrinks to benchmarking papers. What would have to be true for me to be wrong: the research community uses this to produce fine-tunes that actually hit FDA breakthrough device designation, which is plausible but not a given.”

Free AI workspace for verified US physicians — GPT-5.4, clinical search, and CME credits

“AI hallucination in clinical settings isn't a UX bug — it's a patient safety risk. No benchmark score changes the liability reality for physicians relying on AI-generated clinical summaries. The CME credit integration is clever marketing, but I'd want to see a year of real-world adverse event data before recommending this for clinical decision support.”